|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/82 | |
| C07D 401/14 | |||
| C07D 417/12 | |||
| C07D 405/12 | |||
| C07D 409/12 | |||
| C07D 401/12 | |||
| A61K 31/4418 | |||
| A61K 31/4427 | |||
| A61P 25/00 | |||
| A61P 11/00 | |||
| A61P 29/00 | |||
| A61P 19/00 |
| (11) | Number of the document | 2258687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10180693.3 |
| Date of filing the European patent application | 2003-02-10 | |
| (97) | Date of publication of the European application | 2010-12-08 |
| (45) | Date of publication and mention of the grant of the patent | 2012-12-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0203301 | 2002-02-12 | GB | |
| 0225385 | 2002-10-31 | GB |
| (72) |
Aston, Nicola, Mary, GB
Bamborough, Paul, GB
Walker, Ann, Louise, GB
|
| (73) |
Glaxosmithkline LLC,
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102,
US
|
| (54) | Nicotinamide derivates useful as P38 inhibitors |
| Nicotinamide derivates useful as P38 inhibitors |